ClinicalTrials.gov
public full text
Public Domain
Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL)
This is a single-centre, prospective, randomized, open-label, controlled trial of 200 infants 42±7 days of age. Subjects will be randomized to one of two open label feeding intervention group: * Intact Cow's Milk Protein Formula Group (CMFG) (n = 100) or * Partially Hydrolysed Whey Formula Group (pHFG) (n = 100).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Infant Formula Supplemented With a Special Fat Formulation for Premature Infants Following Discharge From Hospital#894799
- Nutrition of Premature Infants With Human Breastmilk Fortifier#885878
- Evaluation of the Nutritional Value of a New Hydrolysed Rice Protein-based Formula#1101404
- Lactoferrin and Lysozyme Supplementation for Long-term Diarrhea Sequelae#852992
- Hypoallergenicity of a Hydrolyzed Protein Infant Formula#831181
Record · ID 851263
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive